What Rite Aid's Earnings Mean For Mutual Fund Investors (RAD)

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

What Rite Aid's Earnings Mean For Mutual Fund Investors (RAD)

Rite Aid company logo
Before the opening bell on Wednesday, Rite Aid (RAD) released its fourth quarter financial results. Here’s what the results mean for mutual fund investors.

Inside RAD’s Results

Earnings

The company reported earnings of $1.835 billion, or $1.79 per share, up from $55.4 million, or 6 cents per share, last year. Analysts expected to see EPS of 7 cents.

Revenue
Revenue increased to $6.85 billion from $6.60 billion last year. Analysts expected to see revenue of $6.80 billion.

Outlook
Looking ahead, RAD expects to see FY2016 EPS between 19 cents and 27 cents.

Expanding Health & Wellness Business

Rite Aid struggled in 2014, but has made a recovery in 2015. So far this year, the stock is up about 19%.

Like other drug companies, Rite Aid is expanding its pharmacy and wellness business to boost sales. During the quarter, prescription sales grew 3.5%; this business segment accounted for 68.1% of total sales.

Mutual Funds to Watch

Investors interested in RAD may also consider the following mutual funds as an alternative to investing directly in the stock. The funds below currently hold the largest stakes in the company.

The Bottom Line

The funds listed above offer investors a stake in RAD, while remaining diversified. Investors may also be interested in CVS Health (CVS).

If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next

Rite Aid company logo

What Rite Aid's Earnings Mean For Mutual Fund Investors (RAD)

Before the opening bell on Wednesday, Rite Aid (RAD) released its fourth quarter financial results. Here’s what the results mean for mutual fund investors.

Inside RAD’s Results

Earnings

The company reported earnings of $1.835 billion, or $1.79 per share, up from $55.4 million, or 6 cents per share, last year. Analysts expected to see EPS of 7 cents.

Revenue
Revenue increased to $6.85 billion from $6.60 billion last year. Analysts expected to see revenue of $6.80 billion.

Outlook
Looking ahead, RAD expects to see FY2016 EPS between 19 cents and 27 cents.

Expanding Health & Wellness Business

Rite Aid struggled in 2014, but has made a recovery in 2015. So far this year, the stock is up about 19%.

Like other drug companies, Rite Aid is expanding its pharmacy and wellness business to boost sales. During the quarter, prescription sales grew 3.5%; this business segment accounted for 68.1% of total sales.

Mutual Funds to Watch

Investors interested in RAD may also consider the following mutual funds as an alternative to investing directly in the stock. The funds below currently hold the largest stakes in the company.

The Bottom Line

The funds listed above offer investors a stake in RAD, while remaining diversified. Investors may also be interested in CVS Health (CVS).

If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next